Literature DB >> 19387118

Vascular factors in diabetes and Alzheimer's disease.

Akihiko Taguchi1.   

Abstract

The homeostasis of neuronal cells is maintained by the cerebral circulation and blood-brain barrier. In addition to age-related physiological decline, diabetes disturbs microvascular functions through mechanisms, including activation of protein kinase C, excess production of reactive oxygen species and cellular activation of the receptor for advanced glycation endproducts (RAGE). Impaired microvasculature has been correlated with pathological changes in both vascular dementia and Alzheimer's disease. Furthermore, RAGE-mediated chronic inflammation initiates a degenerative positive feedback loop between endothelium and neuronal cells. The levels of circulating CD34+ cells, which support maintenance of the microvasculature and are decreased in diabetes, have been proposed to provide a marker of the contribution of cerebrovascular factors in patients with cognitive impairment.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19387118     DOI: 10.3233/JAD-2009-0975

Source DB:  PubMed          Journal:  J Alzheimers Dis        ISSN: 1387-2877            Impact factor:   4.472


  20 in total

Review 1.  Type 2 diabetes mellitus, dyslipidemia, and Alzheimer's disease.

Authors:  Cynthia M Carlsson
Journal:  J Alzheimers Dis       Date:  2010       Impact factor: 4.472

Review 2.  Blockade of brain angiotensin II AT1 receptors ameliorates stress, anxiety, brain inflammation and ischemia: Therapeutic implications.

Authors:  Juan M Saavedra; Enrique Sánchez-Lemus; Julius Benicky
Journal:  Psychoneuroendocrinology       Date:  2010-10-29       Impact factor: 4.905

Review 3.  The neglected co-star in the dementia drama: the putative roles of astrocytes in the pathogeneses of major neurocognitive disorders.

Authors:  W K Jo; A C K Law; S K Chung
Journal:  Mol Psychiatry       Date:  2014-01-07       Impact factor: 15.992

4.  Cilostazol Use Is Associated with Reduced Risk of Dementia: A Nationwide Cohort Study.

Authors:  Shu-Yu Tai; Chen-Yu Chien; Yu-Han Chang; Yuan-Han Yang
Journal:  Neurotherapeutics       Date:  2017-07       Impact factor: 7.620

5.  Neurocognitive SuperAging in Older Adults Living With HIV: Demographic, Neuromedical and Everyday Functioning Correlates.

Authors:  Rowan Saloner; Laura M Campbell; Vanessa Serrano; Jessica L Montoya; Elizabeth Pasipanodya; Emily W Paolillo; Donald Franklin; Ronald J Ellis; Scott L Letendre; Ann C Collier; David B Clifford; Benjamin B Gelman; Christina M Marra; J Allen McCutchan; Susan Morgello; Ned Sacktor; Dilip V Jeste; Igor Grant; Robert K Heaton; David J Moore
Journal:  J Int Neuropsychol Soc       Date:  2019-03-20       Impact factor: 2.892

6.  Diabetes Mellitus and Blood-Brain Barrier Dysfunction: An Overview.

Authors:  Shikha Prasad; Ravi K Sajja; Pooja Naik; Luca Cucullo
Journal:  J Pharmacovigil       Date:  2014-06

7.  Exendin-4 Reverses Biochemical and Functional Alterations in the Blood-Brain and Blood-CSF Barriers in Diabetic Rats.

Authors:  Caroline Zanotto; Fabrício Simão; Manuela Sangalli Gasparin; Regina Biasibetti; Lucas Silva Tortorelli; Patrícia Nardin; Carlos-Alberto Gonçalves
Journal:  Mol Neurobiol       Date:  2016-03-01       Impact factor: 5.590

8.  Cranial volume, mild cognitive deficits, and functional limitations associated with diabetes in a community sample.

Authors:  Andrea L Christman; Tracy D Vannorsdall; Godfrey D Pearlson; Felicia Hill-Briggs; David J Schretlen
Journal:  Arch Clin Neuropsychol       Date:  2009-11-25       Impact factor: 2.813

9.  Atorvastatin ameliorates depressive behaviors and neuroinflammatory in streptozotocin-induced diabetic mice.

Authors:  Zhang Hai-Na; Yu Xu-Ben; Tang Cong-Rong; Cao Yan-Cheng; Yang Fan; Xu Lei-Mei; Sun Ruo-Lan; Wang Ye-Xuan; Liang Jing
Journal:  Psychopharmacology (Berl)       Date:  2019-11-30       Impact factor: 4.530

Review 10.  Diabetes mellitus and disturbances in brain connectivity: a bidirectional relationship?

Authors:  Rodrigo B Mansur; Danielle S Cha; Hanna O Woldeyohannes; Joanna K Soczynska; Andre Zugman; Elisa Brietzke; Roger S McIntyre
Journal:  Neuromolecular Med       Date:  2014-06-29       Impact factor: 3.843

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.